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Abstract 
Stroke is a leading cause of death and dis-
ability, leading to the development of various
stroke  models  to  test  new  treatments,  most
commonly in the rat. Human stroke trials focus
on disability, related primarily to neurological
deficits. To better model the clinical applica-
tion of these treatments, many behavioral tests
have  been  developed  using  the  rat  stroke
model. We performed a systematic review of all
the behavioral outcome measures used in pub-
lished studies of human neural stem cell trans-
plantation in rat stroke models. The reviewed
tests include motor, sensory, cognitive, activity,
and combination tests. For each test, we give a
brief description, trace the origin of the test,
and discuss test performance in the reviewed
studies. We conclude that while many behav-
ioral tests are available for this purpose, there
does not appear to be consensus on an optimal
testing strategy.
Introduction
The majority of our very limited understand-
ing of the pathophysiology of stroke is a direct
result of the use of animal models. We know
too little about the complex molecular and cel-
lular events of stroke to allow for in vitro or
computer  models,  and  we  cannot  yet  access
this  information  in  human  stroke  victims,
although  rapid  advances  in  stroke  imaging
holds promise.
While stroke models have been developed in
many species, the rat is by far the most com-
monly used.1,2 There are a variety of models
that allow for control over the size and location
of  focal  ischemia  in  the  rat  brain  causing
ischemic  stroke  (IS),  and  several  models  of
intracerebral  and  subarachnoid  hemorrhage
as well.2
The majority of preclinical testing of new
stroke treatments has focused on the outcome
of reducing lesion volume relative to controls.
This strategy makes intuitive sense, but there
has been a remarkable number of translation-
al failures in stroke, prompting great debate
about the discrepancy between the results of
these interventions in animals and humans.3
One explanation could be that the stroke mod-
els are invalid because the biology of humans
and  animals  is  too  fundamentally  different.
Few authors believe this to be the case, howev-
er, because what is currently known about the
pathophysiology of stroke appears to be very
similar in the various species used and in non-
human primates. Another explanation could be
that apples are being compared to oranges, as
lesion volume differences in the animals may
not correlate with the neurological and func-
tional  outcomes  used  in  human  trials.  This
appears to be likely, as it is clear that there is
only  modest  correlation  between  cerebral
lesion  size  and  severity  of  neurological  and
functional deficits in humans. For example, a
very small lesion in the brainstem may cause
total paralysis of one side of the body, but large
lesions  encompassing  most  of  one  temporal
lobe may cause only subtle cognitive deficits
that are not appreciable to casual observation.
There is a need, therefore, to develop neuro-
logical outcome measures for the stroke mod-
els,  usually  termed  behavioral  or  functional
outcome measures, which might better predict
the ability of a new treatment to improve neu-
rological deficits following human stroke. This
has proved to be more difficult in rats than was
perhaps initially thought, as it turns out that
very large cerebral lesions in rats may cause
only subtle and/or transient changes on casual
observation.  Most  of  the  behavioral  tests
described were developed in a nonsystematic
manner  during  the  refinement  of  particular
stroke  models  or  with  experiments  of  novel
treatments,  making  it  difficult  to  compare
across published studies.
Rat stroke models
Like humans, the rat brain has two cerebral
hemispheres with an exterior of grey matter
cortex and an interior of white matter and grey
basal ganglia, as well as a brainstem and cere-
bellum.  The  rat  brain  is  smooth  surfaced
(lissencephalic),  unlike  the  convolutions  of
gyri  and  sulci  of  the  human  brain  (gyren-
cephalic), but there are motor and somatosen-
sory  cortices.  The  rat  brain  has  much  less
hemispheric  white  matter  than  the  human
brain. 
Lesions of motor cortex cause contralateral
weakness,  in  coordination,  and  mobility
deficits.  The  portion  of  the  motor  cortex
injured will determine whether the forelimb,
hind limb, or both are involved; the same is
true for sensory loss with lesions of the senso-
ry cortex. Injury to the striatum and deep white
matter causes combinations of motor or senso-
ry deficits. Cognitive deficits can be found with
injury to most areas of the brain, but particu-
larly with cortical injury.
The most commonly used rat stroke model is
intraluminal  filament  middle  cerebral  artery
occlusion (ifMCAO), which can be transient
(tifMCAO) of varying duration, commonly 30 to
120 minutes, or permanent (pifMCAO). In this
model,  various  types  of  filament,  typically
nylon sutures with coated or non-coated tips,
are  inserted  and  advanced  up  the  internal
carotid  artery  (ICA)  until  they  lodge  in  the
anterior cerebral artery (ACA), thereby occlud-
ing  the  origin  of  the  middle  cerebral  artery
(MCAO).  Short  durations  of  ischemia  cause
selective neuronal loss without disruption of
tissue architecture, while longer durations of
ischemia cause frank necrosis of varying vol-
ume of the MCA territory. A shorter duration of
tifMCAO tends to cause infarcts primarily of
the striatum, as collateral circulation on the
surface of the brain appears to allow the cortex
to be spared. Brief duration tifMCAO would,
therefore, be expected to produce mild motor
and sensory deficits, while longer duration of
tifMCAO and pifMCAO would be expected to
produce more severe motor, sensory, and cog-
nitive deficits. These procedures can be com-
bined with transient or permanent occlusion of
the carotid or vertebral arteries to increase the
lesion size and corresponding deficits.
With  craniotomy,  it  is  possible  to  directly
occlude the distal MCA (dMCAO) with suture,
clips, or cautery. This can also be transient or
permanent (tdMCAO or pdMCAO), and can be
combined with concomitant transient common
carotid  artery  occlusion  (tCCAO)  to  cause
more severe ischemia. This occlusion occurs
more  distally  along  the  MCA  than  ifMCAO,
which tends to cause cortical infarcts sparing
the striatum, producing variable motor, senso-
ry, and cognitive deficits.
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compounds  in  the  blood  may  produce  focal
brain  injuries  via  micro-  or  macro-vascular
thromboses,  with  or  without  craniotomy.
These photochemical stroke models cause dis-
crete  injuries  of  various  size  and  location,
leading to variable motor, sensory, and cogni-
tive deficits.
Emboli may be introduced into any of the
cervical arteries to occlude cerebral arteries of
various  sizes  depending  on  the  size  of  the
embolic  materials.  These  embolic  ischemic
stroke models (EISM) can use either clot or
non-clot  materials  such  as  metal  or  plastic
spheres.  Clot  can  be  made  from  various
sources  and  processed  in  different  ways  to
encourage or discourage spontaneous throm-
bolysis, while non-clot EISM are permanent.
Attempts have been made to create EISM that
selectively cause MCAO, but in general, most
of  these  models  cause  single  or  multiple
infarcts of variable location and size, therefore
causing variable motor, sensory, and cognitive
deficits.
Intracerebral  hemorrhage  models  can  be
targeted (such as by injection of blood or pro-
teolytic  enzymes)  or  untargeted  (such  as
thrombolytic  administration  and  blood  pres-
sure  elevation),  causing  variable  deficits.
Subarachnoid  models  may  produce  focal
deficits, but more commonly produce stupor or
death due to the rapid increase in intracranial
pressure.
Materials and Methods
We performed a systematic review with the
objective of identifying all the behavioral out-
come measures used for human neural stem
cell transplantation in animal stroke models.
We searched PubMed, Science Citation Index,
and  Biological  Abstracts  for  articles  that
matched our inclusion criteria (Appendix 1).
We included any behavioral test used in con-
trolled  experiments  transplanting  cultured
human cells expressing neural stem cell mark-
ers in vitro prior to transplantation into a rat
stroke model of focal cerebral ischemia, intrac-
erebral hemorrhage, or subarachnoid hemor-
rhage. Our search was performed in April of
2010, and limited to full articles in the English
language published prior to January 1, 2010.
No other limits were used. This searched pro-
duced  510  results.  We  reviewed  titles,
abstracts, or full articles to determine if our
inclusion criteria were met. We found 21 arti-
cles  that  matched  our  inclusion  criteria.4-25
The references included in these articles were
reviewed for more matching studies, but none
were  found.  An  ischemic  stroke  model  was
used in 19 studies while two studies used an
intracerebral hemorrhage model; none of the
included studies used a model of subarachnoid
hemorrhage.
For  each  test  identified,  we  give  a  brief
description, the origin of the test as could be
determined  by  tracing  references  back  from
the reviewed article, and a discussion of the
test performance in the reviewed studies. The
tests are categorized as motor, sensory, cogni-
tive, activity, and combination tests, although
the true neurological function assessed by any





The elevated body swing test (EBST) con-
sists of lifting the rat by the base of the tail,
whereby it will laterally swing its body to one
side or the other; repeated trials are performed
to see if it has a bias toward one side. A swing
bias toward one side has been interpreted as a
motor deficit.
Origin
In 1995 Borlongan et al. reported the devel-
opment of the EBST and its successful use to
distinguish  a  unilateral  Parkinson's  disease
rat model from sham.26 In a separate 1995 arti-
cle, Borlongan et al. reported that the EBST
successfully distinguished sham from 60 min
tifMCAO rats up to two months after stroke.27
Use in human neural stem cell transplanta-
tion studies
Several  studies  reported  significant
improvement of grafted rats relative to control
on the EBST up to six months after transplan-




The  rotarod  is  a  horizontal  cylinder  large
enough to stand on, which is then rotated at a
variable speed or acceleration until the rat falls
off.  Diminished  speed  tolerance  has  been
interpreted as a motor deficit.
Origin
In 1957 Dunham et al. reported the develop-
ment of the rotarod test to assess neuroactive
drugs on rodents, and in 1994, Hamm et al.
found it useful to distinguish rats with trau-
matic  brain  injury  from  sham.28,29 In  2000
Chen et al. reported that the rotarod test suc-
cessfully  distinguished  pre-stroke  rats  from
the same rats up to one week after 120 min
tifMCAO.30
Use in human neural stem cell
transplantation studies
Several  studies  reported  significant
improvement of grafted rats relative to control
on  the  rotarod  test  up  to  two  months  after
transplantation,  using  60,  90,  and  120  min




The turning-in-alley test (TIAT) consists of
the rat being placed facing the back wall of an
alley, and the time for turning around recorded
over  repeated  trials.  A  longer  time  to  turn
around has been interpreted as a motor deficit.
Origin
In 2004 Chu et al. reported the development
of the TIAT and stated that it successfully dis-
tinguished pre-stroke rats from the same rats
up to one month after 90 min tifMCAO.11
Use in human neural stem cell transplanta-
tion studies
In the same 2004 report, Chu et al. stated
there was significant improvement of grafted
rats relative to control on the TIAT test up to
one month after transplantation.
Rotameter
Description
The rotameter test consists of the rat mov-
ing in a bowl-shaped device that counts turns
and direction, usually after the administration
of amphetamine to increase rotations. A ten-
dency to rotation primarily in one direction has
been interpreted as a motor deficit.
Origin
In 1970 Ungerstedt et al. reported the devel-
opment of the rotameter test, and stated that it
successfully  distinguished  a  unilateral
Parkinson's disease rat model from control.31
In  2001  Veizovic  et  al.  reported  that  the
rotameter  test  successfully  distinguished
sham and 60 min tifMCAO rats up to seven
weeks after stroke.32
Use in human neural stem cell transplanta-
tion studies
Two  studies  reported  significant  improve-
ment of grafted rats relative to control on the
rotameter test up to three months after trans-
plantation in 60 and 70 min tifMCAO rats.13, 23
Ledged beam
Description 
The ledged beam test (LBT) consists of the
rat walking on a narrow beam with ledges on
the sides and counting each time a hind limb
touches the ledge. Asymmetry has been inter-
preted as a motor deficit.
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In 2002 Schallert et al. reported the develop-
ment of the LBT and stated that it successfully
distinguished MCAO rats from sham.33
Use in human neural stem cell transplanta-
tion studies
One study reported significant improvement
of grafted rats relative to control on the LBT up
to one month after transplantation in rats with
pdMCAO plus 60 min tCCAO.14
Cylinder
Description 
The cylinder test consists of the rat being
placed  in  a  cylinder  that  is  wide  enough  to
allow movement and to encourage wall explo-
ration. The rat explores the space by rearing
and placing one or both forelimbs on the cylin-
der wall, and then using one or both forelimbs
to land back on the floor. All of these move-
ments may be counted for a certain length of
time. Decreased use of the impaired forelimb
has been interpreted as a motor deficit.
Origin
In 2000 Schallert et al. reported the develop-
ment of the cylinder test and its successful use
to distinguish a unilateral Parkinson's disease
rat model from sham.34 In a separate 2000 arti-
cle, Schallert et al. reported that the cylinder
test  successfully  distinguished  sham  and
pdMCAO rats up to one month after stroke.35
Use in human neural stem cell transplanta-
tion studies
Two  studies  reported  significant  improve-
ment of grafted rats relative to control on the
cylinder test up to two months after transplan-
tation, using rats with 90 min tifMCAO and
pdMCAO plus 60 min tCCAO.17,24
Staircase
Description
The staircase test consists of the rat being
placed  in  a  box  with  narrow  staircases
descending on both sides with a food pellet on
each step. Each step is progressively further
away and harder to reach with the forelimb.
Limitations of the number of pellets retrieved
have been interpreted as a motor deficit. 
Origin
In 1991 Montoya et al. reported the develop-
ment of the staircase test and its successful
use to distinguish rats with unilateral cortical
suction lesions from sham.36 In 2009 Hicks et
al. reported that the staircase test successfully
distinguished  sham  and  rats  with  pdMCAO
plus  60  min  of  bilateral  tCCAO  up  to  two
months after stroke.24
Use in human neural stem cell
Transplantation studies
In the same 2009 report, Hicks et al. stated
that they did not see significant improvement
of grafted rats relative to control on the stair-





The  limb  placing  test  (LPT)  scores  limb
placing reactions to visual, tactile, and propri-
oceptive stimuli, usually by using the edge of a
table  to  produce  the  stimulus.  Slow,  incom-
plete, or absent placing has been interpreted
as a sensory deficit of the tested modality. 
Origin
In 1989 De Ryck et al. reported the develop-
ment of the LPT and its successful use to dis-
tinguish photochemical stroke model rats from
sham up to three weeks after stroke.37
Use in human neural stem cell transplanta-
tion studies
Several  studies  reported  significant
improvement of grafted rats relative to control
on the LPT up to three months after transplan-
tation,  using  60  and  90  min  tifMCAO,  and
intrastriatal collagenase rat models.9,11,12,18,23
Adhesive removal
Description
The adhesive removal test (ART) consists of
placing a small adhesive-backed tape circle or
strip to both forelimbs. The times to contact
and/or  removal  are  recorded.  A  variant  test
involves  using  progressively  larger  adhesive
pieces on the contralateral side with progres-
sively smaller dots on the ipsilateral side. A
longer  time  for  contact  and  removal  of  the
adhesive material has been interpreted as a
sensory deficit of that limb. 
Origin
In 1982 Schallert et al. reported the develop-
ment of the ART and its successful use to dis-
tinguish a unilateral Parkinson's disease rat
model  from  sham.38 In  1992  Markgraf et  al.
reported  that  the  ART  successfully  distin-
guished sham from pdMCAO rats up to 20 days
after stroke.39
Use in human neural stem cell transplanta-
tion studies
Several  studies  reported  significant
improvement of grafted rats relative to control
on the ART up to three months after transplan-





The  passive  avoidance  test  (PAT)  uses  a
mild electric shock to teach the animal to move
and stay away from certain areas of the cage.
Diminished ability to do so has been interpret-
ed as a deficit of learning.40
Origin
In 1978 Sanberg et al. reported the develop-
ment of the PAT and its successful use to dis-
tinguish a unilateral Huntington's disease rat
model  from  sham.38 In  1993  Nishino  et  al.
reported  that  the  PAT  successfully  distin-
guished sham from 60 min tifMCAO rats up to
3 months after stroke.41
Use in human neural stem cell transplanta-
tion studies
Several  studies  reported  significant
improvement of grafted rats relative to control
on the PAT up to six months after transplanta-




The locomotor activity test (LAT) consists of
one of several systems to quantify open field
locomotor activity, such as specific movements
around the cage during a period of time. Most
of  these  systems  use  direct  observation  or
beams of light arranged in a grid, with a com-
puter recording each time the animal moves
through a beam. Changes in activity patterns
with stroke, usually hyperactivity, have been
interpreted  to  be  either  motor  or  cognitive
deficits. Motor deficits could cause decreased
movement in general or a different pattern of
movements  to  compensate  for  the  deficits.
Cognitive deficits could conceivably lead the
animal  to  explore  the  environment  more
because of a deficit of spatial perception or
memory.
Origin
In 1987 Sanberg et al. reported the develop-
ment of a LAT and its successful use to distin-
guish  rats  that  received  neuroactive  drugs
from control.42 In 1995 Borlongan et al. report-
ed  that  the  LAT  successfully  distinguished
sham from 60 min tifMCAO rats up to 2 months
after stroke.27
Use in human neural stem cell transplanta-
tion studies
One study reported significant improvement
of grafted rats relative to control on the LAT up
to two months after transplantation, using a
30min tifMCAO rat model.16
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Neurological severity score
Description
The neurological severity score (NSS) is a
composite of motor (muscle status, abnormal
movement), sensory (visual, tactile, proprio-
ceptive), reflex, and balance tests. 
Origin
In 2002 Li et al. reported the development of
the NSS and its successful use to distinguish
120 min tifMCAO rats from sham up to two
weeks after stroke.43
Use in human neural stem cell transplanta-
tion studies
Several  studies  reported  significant
improvement of grafted rats relative to control
on the NSS up to two months after transplanta-




The motor behavior index (MBI) is a com-
posite  of  spontaneous  activity,  symmetry  of
movement of the limbs when suspended by the
tail,  climbing  a  wire  cage,  and  reaction  to
touch of the body and vibrissae.
Origin
In 1995 Garcia et al. reported the develop-
ment of the MBI and its successful use to dis-
tinguish 30 and 60 min tifMCAO, and pifMCAO
rats from sham up to one week after stroke.44
Use in human neural stem cell transplanta-
tion studies
One study reported significant improvement
of grafted rats relative to control on the MBI up
to three weeks after transplantation, using a
120 min tifMCAO rat model.15
Bederson
Description
The Bederson test was a composite of fore-
limb flexion with tail suspension, response to
lateral push, and circling with walking.
Origin
In 1986 Bederson et al. reported the develop-
ment of the Bederson test and its successful
use  to  distinguish  proximal  versus  distal
pifMCAO rats at one day after stroke.45
Use in human neural stem cell transplanta-
tion studies
One study reported significant improvement
of  grafted  rats  relative  to  control  on  the
Bederson test up to two months after trans-
plantation,  using  a  30  min  tifMCAO  rat
model.16
Conclusions
Animal stroke models, primarily using the
rat,  are  currently  necessary  to  further  our
understanding of the disease and to test new
treatments  in  the  hopes  of  improving  out-
comes for our patients. The ability of a new
treatment to reduce infarct volume in an ani-
mal  model  of  stroke  has  not  translated  to
improvement  on  neurological  and  functional
outcome measures in human trials. There are
many behavioral outcome measures that have
been developed for rat stroke models assessing
multiple  domains  of  neurological  function.
Despite this there does not appear to be con-
sensus on an optimal behavioral testing strat-
egy in any particular model, or for any particu-
lar  category  of  treatment  under  evaluation.
Hopefully,  in  the  coming  years,  we  will  see
multiple new treatments successfully translate
promising new interventions from preclinical
studies  into  positive  clinical  trials,  which
would then allow us to go back and re-assess
the most useful behavioral outcome measures
in the various rat stroke models. Until such
information is available, we feel that a reason-
able testing strategy would include an assess-
ment of multiple domains of neurological func-
tion  including  motor,  sensory,  and  cognitive
tests, which can be tailored to the stroke model
being used, and refined through iterative use
in the lab of each investigator, based on their
experimental aims and available resources.
References
1. Durukan A, Tatlisumak T. Acute ischemic
stroke:  overview  of  major  experimental
rodent models, pathophysiology, and ther-
apy of focal cerebral ischemia. Pharmacol
Biochem Behav 2007;87:179-97.
2. Wang-Fischer Y. Manual of stroke models
in rats. Boca Raton: CRC Press; 2009.
3. O'Collins V, Macleod M, Donnan G, et al.
1,026  experimental  treatments  in  acute
stroke. Ann Neurol 2006;59:467-77.
4. Paxinos  G,  Watson  C.  The  rat  brain  in
stereotaxic  coordinates.  6th  ed.
Amsterdam: Elsevier; 2007.
5. Borlongan CV, Tajima Y, Trojanowski JQ, et
al. Cerebral ischemia and CNS transplan-
tation: differential effects of grafted fetal
rat  striatal  cells  and  human  neurons
derived from a clonal cell line. Neuroreport
1998;9:3703-9.
6. Borlongan CV, Tajima Y, Trojanowski JQ, et
al.  Transplantation  of  cryopreserved
human embryonal carcinoma-derived neu-
rons  (NT2N  cells)  promotes  functional
recovery  in  ischemic  rats.  Exp  Neurol
1998;149:310-21.
7. Borlongan CV, Saporta S, Poulos SG, et al.
Viability  and  survival  of  hNT  neurons
determine degree of functional recovery in
grafted  ischemic  rats.  Neuroreport
1998;9:2837-42.
8. Saporta  S,  Borlongan  CV,  Sanberg  PR.
Neural  transplantation  of  human  neu-
roteratocarcinoma  (hNT)  neurons  into
ischemic  rats.  A  quantitative  dose-
response  analysis  of  cell  survival  and
behavioral  recovery.  Neuroscience  1999;
91:519-25.
9. Jeong SW, Chu K, Jung KH, et al. Human
neural stem cell transplantation promotes
functional  recovery  in  rats  with  experi-
mental intracerebral hemorrhage. Stroke
2003;34:2258-63.
10. Kang S, Lee D, Bae Y, et al. Improvement of
neurological  deficits  by  intracerebral
transplantation of human adipose tissue-
derived  stromal  cells  after  cerebral
ischemia in rats. Exp Neurol 2003;183:355-
66.
11. Chu K, Kim M, Park KI, et al. Human neu-
ral  stem  cells  improve  sensorimotor
deficits in the adult rat brain with experi-
mental  focal  ischemia.  Brain  Res  2004;
1016:145-53.
12. Chu K, Park KI, Lee ST, et al. Combined
treatment of vascular endothelial growth
factor  and  human  neural  stem  cells  in
experimental  focal  cerebral  ischemia.
Neurosci Res 2005;53:384-90.
13. Pollock K, Stroemer P, Patel S, et al. A con-
ditionally  immortal  clonal  stem  cell  line
from human cortical neuroepithelium for
the  treatment  of  ischemic  stroke.  Exp
Neurol 2006;199:143-55.
14. Bliss  TM,  Kelly  S,  Shah  AK,  et  al.
Transplantation of hNT neurons into the
ischemic cortex: cell survival and effect on
sensorimotor  behavior.  J  Neurosci  Res
2006;83:1004-14.
15. Kim D, Park S, Lee S, et al. Effect of human
embryonic stem cell-derived neuronal pre-
cursor cell transplantation into the cere-
bral  infarct  model  of  rat  with  exercise.
Neurosci Res 2007;58:164-75.
16. Hara K, Matsukawa N, Yasuhara T, et al.
Transplantation  of  post-mitotic  human
neuroteratocarcinoma-overexpressing
Nurr1 cells provides therapeutic benefits
in experimental stroke: In vitro evidence
of expedited neuronal differentiation and
GDNF  secretion.  J  Neurosci  Res
2007;85:1240-51.
17. Daadi  MM,  Maag  A-L,  Steinberg  GK.
Adherent  Self-Renewable  Human
Embryonic Stem Cell-Derived Neural Stem
Cell  Line:  Functional  Engraftment  in
Experimental  Stroke  Model.  PLoS  One
2008;3:e1644.
18. Lee ST, Chu K, Jung KH, et al. Anti-inflam-
Review
[page 38] [Neurology International 2011; 3:e10]matory mechanism of intravascular neural
stem cell transplantation in haemorrhagic
stroke. Brain 2008;131:616-29.
19. Kim S, Yoo S, Park T, et al. Neural induc-
tion with neurogenin1 increases the ther-
apeutic effects of mesenchymal stem cells
in  the  ischemic  brain.  Stem  Cells
2008;26:2217-28.
20. Lee TH, Yoon JG. Intracerebral transplan-
tation  of  human  adipose  tissue  stromal
cells after middle cerebral artery occlusion
in rats. J Clin Neurosci 2008;15:907-12.
21. Liu  YP,  Seckin  H,  Izci  Y,  et  al.
Neuroprotective  effects  of  mesenchymal
stem cells derived from human embryonic
stem  cells  in  transient  focal  cerebral
ischemia  in  rats.  J  Cereb  Blood  Flow
Metab 2009;29:780-91.
22. Zhang P, Li J, Liu Y, et al. Human neural
stem cell transplantation attenuates apop-
tosis and improves neurological functions
after  cerebral  ischemia  in  rats.  Acta
Anaesthesiol Scand 2009;53:1184-91.
23. Stroemer P, Patel S, Hope A, et al. The neu-
ral  stem  cell  line  CTX0E03  promotes
behavioral recovery and endogenous neu-
rogenesis after experimental stroke in a
dose-dependent  fashion.  Neurorehabil
Neural Repair 2009;23:895-909.
24. Hicks A, Lappalainen R, Narkilahti S, et al.
Transplantation of human embryonic stem
cell-derived  neural  precursor  cells  and
enriched environment after cortical stroke
in rats: cell survival and functional recov-
ery. Eur J Neurosci 2009;29:562-74.
25. Yang KL, Chen MF, Liao CH, et al. A simple
and  efficient  method  for  generating
Nurr1-positive  neuronal  stem  cells  from
human  wisdom  teeth  (tNSC)  and  the
potential  of  tNSC  for  stroke  therapy.
Cytotherapy 2009;11:606-17.
26. Borlongan  C,  Sanberg  P.  Elevated  body
swing test: a new behavioral parameter for
rats  with  6-hydroxydopamine-induced
hemiparkinsonism.  J  Neurosci
1995;15:5372-8.
27. Borlongan  C,  Cahill  D,  Sanberg  P.
Locomotor and passive avoidance deficits
following occlusion of the middle cerebral
artery. Physiol Behav 1995;58:909-17.
28. Dunham N, Miya T. A note on a simple
apparatus  for  detecting  neurological
deficit in rats and mice. J Am Pharm Assoc
Am Pharm Assoc (Baltim) 1957;46:208-9.
29. Hamm R, Pike B, O'Dell D, e al. The rotar-
od test: an evaluation of its effectiveness
in assessing motor deficits following trau-
matic brain injury. J Neurotrauma 1994;
11:187-96.
30. Chen J, Li Y, Chopp M. Intracerebral trans-
plantation  of  bone  marrow  with  BDNF
after  MCAo  in  rat.  Neuropharmacology
2000;39:711-6.
31. Ungerstedt U, Arbuthnott G. Quantitative
recording  of  rotational  behavior  in  rats
after  6-hydroxy-dopamine  lesions  of  the
nigrostriatal dopamine system. Brain Res
1970;24:485-93.
32. Veizovic  T,  Beech  J,  Stroemer  R,  et  al.
Resolution of stroke deficits following con-
tralateral grafts of conditionally immortal
neuroepithelial stem cells. Stroke 2001;32:
1012-9.
33. Schallert  T  WM,  Fleming  SM.
Disentangling  multiple  types  of  recovery
from brain injury. In: Krieglstein J KS, ed.
Pharmacology  of  Cerebral  Ischemia.
Stuttgart:  Medpharm  Scientific
Publishers; 2002. pp. 201-216.
34. Emerich DF, Dean RL, Sanberg PR. Central
nervous system diseases: innovative ani-
mal models from lab to clinic. Totowa, NJ:
Humana Press; 2000.
35. Schallert  T,  Fleming  S,  Leasure  J,  et  al.
CNS plasticity and assessment of forelimb
sensorimotor  outcome  in  unilateral  rat
models of stroke, cortical ablation, parkin-
sonism  and  spinal  cord  injury.
Neuropharmacology 2000;39:777-87.
36. Montoya C, Campbell-Hope L, Pemberton
K, Dunnett S. The "staircase test": a meas-
ure of independent forelimb reaching and
grasping  abilities  in  rats.  J  Neurosci
Methods 1991;36:219-28.
37. De Ryck M, Van Reempts J, Borgers M, et
al.  Photochemical  stroke  model:  flunar-
izine prevents sensorimotor deficits after
neocortical infarcts in rats. Stroke 1989;
20:1383-90.
38. Schallert T, Upchurch M, Lobaugh N, et al.
Tactile extinction: distinguishing between
sensorimotor  and  motor  asymmetries  in
rats with unilateral nigrostriatal damage.
Pharmacol  Biochem  Behav  1982;16:455-
62.
39. Markgraf  C,  Green  E,  Hurwitz  B,  et  al.
Sensorimotor and cognitive consequences
of middle cerebral artery occlusion in rats.
Brain Res 1992;575:238-46.
40. Sanberg P, Lehmann J, Fibiger H. Impaired
learning  and  memory  after  kainic  acid
lesions of the striatum: a behavioral model
of  Huntington's  disease.  Brain  Res
1978;149:546-51.
41. Nishino  H,  Koide  K,  Aihara  N,  et  al.
Striatal  grafts  in  the  ischemic  striatum
improve pallidal GABA release and passive
avoidance. Brain Res Bull 1993;32:517-20.
42. Sanberg  P,  Zoloty  S,  Willis  R,  et  al.
Digiscan  activity:  automated  measure-
ment  of  thigmotactic  and  stereotypic
behavior  in  rats.  Pharmacol  Biochem
Behav 1987;27:569-72.
43. Li Y, Chen J, Chen XG, et al. Human mar-
row stromal cell therapy for stroke in rat:
neurotrophins  and  functional  recovery.
Neurology 2002;59:514-23.
44. Garcia J, Wagner S, Liu K, Hu X. Neurolo  -
gical deficit and extent of neuronal necro-
sis attributable to middle cerebral artery
occlusion  in  rats.  Statistical  validation.
Stroke 1995;26:627-34; discussion 635.
45. Bederson J, Pitts L, Tsuji M, et al. Rat mid-
dle cerebral artery occlusion: evaluation of
the model and development of a neurolog-
ic examination. Stroke 1986;17:472-6.
Review
[Neurology International 2011; 3:e10] [page 39]